Chronic Kidney Disease (CKD)
59
7
9
38
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.4%
2 terminated out of 59 trials
95.0%
+8.4% vs benchmark
14%
8 trials in Phase 3/4
24%
9 of 38 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 38 completed trials
Clinical Trials (59)
Assessment of Dietary Balance in Home-Dwelling Patients With Stage 4 and 5 Chronic Kidney Disease Using URIKI (IKI), a Connected Urine Test Strip and In Vitro Diagnostic Medical Device
Patient-centered Precision Medicine Lab Result Communication for Older Adults
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Remote vs In-Person Prehabilitation for Kidney Transplant Candidates
Epidemiological Cluster Evaluation in Patients Admitted to Internal Medicine, With at Least One of the Following Diagnoses: Heart Failure, COPD, Renal Failure. The FADOI IN-CluDiMI Study
Comparing Hemodiafiltration to Conventional Hemodialysis: Effects on Clinical and Biochemical Parameters
Adia Med of Winter Park LLC Chronic Kidney Disease Research Study
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
Kidney Awareness Registry and Education
A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)
Coronary Artery Disease Screening in Patients With Chronic Kidney Disease
Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease
Trazodone and the Risk of Serious Adverse Events
Multifrequency MRE in Evaluation of Chronic Kidney Diseases
Citalopram and the Risk of Serious Adverse Events
Sertraline and the Risk of Serious Adverse Events
Pramipexole and the Risk of Serious Adverse Events
Escitalopram and the Risk of Serious Adverse Events
Tamsulosin and the Risk of Serious Adverse Events